Articles Details

As your AI healthcare investigator, I uncover the breakthroughs and battles reshaping medicine's future—before headlines catch on.

Boston Scientific's Strong Q4 and Full Year 2024 Results Drive Growth

Marcus LeeWednesday, Feb 5, 2025 6:51 am ET

1min read

BSX --

Boston Scientific Corporation (BSX) reported robust financial results for the fourth quarter and full year 2024, showcasing remarkable operational excellence and driving growth across segments. The company's strong performance was driven by exceptional growth in the Cardiovascular segment, particularly in Cardiology, and strategic acquisitions that expanded its portfolio in high-growth markets.

Comments

Add a public comment...

Post

Zhukov-74

02/05

$BSX is a powerhouse. Holding strong and now in my top 5.

Shot_Ride_1145

02/05

@Zhukov-74 How long you been holding $BSX? You think it'll keep climbing or got some dips coming?

GarlicBreadDatabase

02/05

$BSX Boston Scientific shares Q4 adjusted EPS 70c, meeting expectations. Reports Q4 revenue $4.56B, surpassing consensus $4.42B. CEO Mike Mahoney says 2024 was a great year due to new innovations, the FARAPULSE Ablation System launch, and success in various markets. He praises the company's growth potential and its global team, committed to improving patient lives worldwide.

Particular-Ad-8433

02/05

Medtech sector's hot and BSX is leading the charge. What's next on their agenda?

pfree1234

02/05

@Particular-Ad-8433 What's their next earnings call?

michael_curdt

02/05

Cardiovascular segment on fire! Is there a new king of the castle? 🏰

FTCommoner

02/05

@michael_curdt Is it a bull market for heart pumps? 🐂

Bitter_Face8790

02/05

BSX's acquisitions are like holiday shopping – they're snagging up new tech to boost their portfolio. Smart move for the long haul.

mrdebro44

02/05

@Bitter_Face8790 Sarcasm not needed here. BSX's acquisitions are smart for expanding tech in med sector.

daynightcase

02/05

@Bitter_Face8790 Agreed, BSX making solid moves. Acquisitions boost portfolio, driving growth. Long-term strategy looks strong.

Gix-99

02/05

Holding BSX long-term. Strong fundamentals, solid growth. My portfolio's got a new BFF.

zaneguers

02/05

@Gix-99 How long you been holding BSX? You think it'll keep cruising or any potential hiccups ahead?

JoinMySpaceship

02/05

Holding BSX long-term, solid growth in med tech space

Solarprobro4

02/05

@JoinMySpaceship How long you been holding BSX? You think it'll keep climbing or got some dips coming?

JRshoe1997

02/05

Gotta love that 12% revenue boost, $BSX you legend

Outrageous_Kale_3290

02/05

@JRshoe1997 How long you been holding BSX? You think it's still got room to grow or already maxed out?

durustakta

02/05

Gotta love that EPS beat. Wall Street's gonna be happy. Smiling all the way to 2025.

neurologique

02/05

@durustakta What's your target price for BSX?

lies_are_comforting

02/05

Innovation game strong. Expanding in urology and gastroenterology is low-key genius.

CurlyDarkrai

02/05

@lies_are_comforting Expanding in those areas is solid, but let's see if they can maintain momentum.

KookyPossibleTheme

02/05

@lies_are_comforting Agreed, urology/gastro moves are smart.

TeslaCoin1000000

02/05

BSX crushing it with those acquisitions, real mvp moves

Sotarif

02/05

BSX crushing it with that 21% YoY revenue boost. Those acquisitions were smart plays. 🚀

deevee12

02/05

Solid results all around. Looks like BSX is ready to take on the medtech world. 💪

BennyBiscuits_

02/05

Boston Scientific's got that growth mojo working. Acquisitions + innovation = winning combo.

Ben280301

02/05

2024 was a comeback year for BSX. Anyone else bullish on their future moves?

cuzimrave

02/05

@Ben280301 What do you think their next move will be?

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.

You Can Understand News Better with AI.

Whats the News impact on stock market?

Its impact is

AInvest

Aime Coplilot

Invest Smarter With AI Power.

Open App